Research Topics
| Henriette ThistedSummaryAffiliation: Aarhus University Hospital Country: Denmark Publications
| Collaborators
|
Detail Information
Publications
Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up studyHenriette Thisted Horsdal
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
J Stroke Cerebrovasc Dis 21:717-25. 2012..We examined whether the preadmission use of sulfonylureas is associated with improved clinical outcome compared with other antidiabetic treatments after hospitalization with ischemic stroke...
Statins and the risk of acute pancreatitis: a population-based case-control studyH Thisted
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
Aliment Pharmacol Ther 23:185-90. 2006..Case reports have suggested that statins may cause acute pancreatitis...
An update on the long-acting insulin analogue glargineHenriette Thisted
Department of Pharmacology, University of Aarhus, Aarhus, Denmark
Basic Clin Pharmacol Toxicol 99:1-11. 2006..In many countries glargine is widely used. Here we present an update on the clinical information available on glargine with respect to glycaemic control, the risk of hypoglycaemia and quality of life in both type 1 and type 2 diabetes...
Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up studyH T Horsdal
Department of Clinical Epidemiology, Aarhus University Hospital, Ole Worms Alle 1150, DK 8000 Aarhus, Denmark
Diabetologia 51:567-74. 2008....
Use of statins and risk of hospitalization with dementia: a Danish population-based case-control studyHenriette Thisted Horsdal
Department of Clinical Epidemiology section, Unit for Psychiatric Research, Aalborg Psychiatric Hospital, University of Aarhus, Aarhus, Denmark
Alzheimer Dis Assoc Disord 23:18-22. 2009..In conclusion, we found a reduced risk of hospitalization with dementia among users of statins, however, whether this association is causal remains to be clarified...
Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control studyHenriette Thisted Horsdal
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
Pharmacoepidemiol Drug Saf 20:331-7. 2011..We examined the risk of hospitalisation with myocardial infarction (MI) among patients treated with sulfonylureas, metformin, insulin, any combination and no antidiabetic pharmacotherapy...
Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugsS P Johnsen
Department of Clinical Epidemiology, Aarhus Sygehus, Aarhus University Hospital, Aarhus and Aalborg, Denmark
Am J Ther 13:134-40. 2006..Furthermore, the 30-day CFR may vary according to type of antidiabetic drug. These differences indicate the need for further examination of the cardiovascular safety of antidiabetic drugs...
Sulfonylureas and the risk of myocardial infarctionHenriette Thisted
Department of Clinical Epidemiology, Aarhus University Hospital, DK-8000 Aarhus C, Denmark
Metabolism 55:S16-9. 2006..Although the hypotheses were stimulated by animal studies and experimental studies using intermediate end points, data on the possible clinical implications in humans remain sparse. However, recent data seem reassuring...
